RhumbLine Advisers’s BioLineRX BLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.5K | Buy |
|
|||||
|
2025
Q1 | $4.52K | Buy |
|
|||||
|
2024
Q4 | $9.14K | Buy |
|
|||||
|
2024
Q3 | $17.5K | Buy |
|
|||||
|
2024
Q2 | $14.6K | Buy |
|
|||||
|
2024
Q1 | $20.5K | Sell |
|
|||||
|
2023
Q4 | $29.5K | Buy |
|
|||||
|
2023
Q3 | $27.9K | Buy |
|
|||||
|
2023
Q2 | $21.7K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $16K | Buy |
|
|||||
|
2022
Q2 | $19K | Hold |
|
|||||
|
2022
Q1 | $25K | Hold |
|
|||||
|
2021
Q4 | $30K | Hold |
|
|||||
|
2021
Q3 | $40K | Buy |
|
|||||
|
2021
Q2 | $38K | Hold |
|
|||||
|
2021
Q1 | $38K | Sell |
|
|||||
|
2020
Q4 | $36K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $5K | Hold |
|
|||||
|
2019
Q1 | $5K | Sell |
|
|||||
|
2018
Q4 | $8K | Hold |
|
|||||
|
2018
Q3 | $20K | Buy |
|